In-vitro studies confirm that the Company’s novel Smart mRNA could drastically reduce off-target liver toxicity, a major issue affecting many cancer drugs
Halia Therapeutics Expands to Abu Dhabi
Leash Bio Announces Multi-Target Agreement with Monte Rosa Therapeutics
SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care.
Attendees invited to Booth #732 for pivotal trial updates and to discuss unmet needs in Parkinson’s care.
Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner
BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral family.
Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
This week AdvaMed held its annual Medtech Conference, designed for those in the medical technology industry.
Nelson Labs on October 1 celebrated a milestone 40th anniversary. Since its humble beginnings in 1985 in University of Utah’s Research Park, Nelson Labs has grown into a trusted, global leader of medical device and pharmaceutical testing.
Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy